A B S T R A C T This study was carried out to determine if, in fasting, an adaptation to utilization of ketones could prevent cerebral dysfunction during periods of acute, insulin-induced glucopenia.
INTRODUCTION
It has been demonstrated that in prolonged fasting, ketoacids are extracted from blood passing through the brain (1) and that the convulsant dose of insulin has to be increased fivefold in order to produce the same incidence of convulsions in fasted as in nonfasted mice (2) . The present study was carried out to elucidate if the adaptation to utilization of ketoacids can render the brain of fasting humans resistant to the ill effects of glucose privation and if enhanced cerebral utilization of 2-hydroxybutyrate (#-OHB)1 can be demonstrated during acute glucopenia. METHODS Obese men weighing 240-403 lb. were studied on a metabolic balance ward. Base line insulin tolerance tests were administered in the postabsorptive state with the subject at bed rest. Repeat tests were carried out in nine subjects after a minimum of 60 days of fasting which had resulted in a mean weight loss of 73 lb. Regular crystalline insulin was injected intravenously. The doses ranged from 0.1 to 0.2 U/kg body weight. Four subjects weighing more than 375 lb. were given the lower (0.1 U/kg) dose. The postfast dose was decreased in proportion to weight loss but for each subject the U/kg body weight ratio was kept constant. Multiple blood samples were drawn during a 2 hr period from a deep forearm vein via an indwelling catheter. Blood 1Abbreviation used in this paper: fi-OHB, ,B-hydroxybutyrate.
INSULIN
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After the fast, the same nine subjects had no insulin reactions.
Changes in insulin levels. To determine if the calculated doses of injected insulin were equivalent before and after weight loss, the maximum concentrations and disappearance slopes were plotted semilogarithmically ( Fig. 1) Initially, plasma glucose returned to basal levels withini 90 to 120 min after insulin but failed to return to the pretest base line level up to the 2 hour interval in the postfast test.
Before the fast period serum free fatty acids (FFA) levels decreased slightly but significantly from base line after the administration of insulin but rose again to original concentrations simnultaneously with the disappearance of the injected insulin from the plasma. With fasting, FFA levels had increased twofold but the response pattern to injected insulin was similar at the end of fasting. The transient fall was significant (P < 0.05) and the restoration to base line levels was complete at the 2 hr interval (Fig. 3) . The per cent decrease from base line levels was slightly greater after fasting, demonstrating that the antilipolytic effect of insulin had re.mained intact.
Before fasting P-OHB levels in the serum were low (mean 0.14 mmoles/liter) and these decreased to 0.09 mmoles/liter 45 min after insulin. With fasting the expected increases occurred, with peak concentrations ranging from 6.08 to 14.13 mmoles/liter (Fig. 3) . The mean for the nine subjects was 8.02±0.37 mmoles/liter. The fall after insulin to a mean of 6.72 mmoles/ liter was significant (P < 0.01). This level was reached at 30 min and persisted to the 45-min intervals. 2 hr after insulin the mean concentration had not returned to base line levels although the difference between the 45 min and the 2 hr level was not statistically significant. In three subjects the 2-hr levels were actually higher than initially. Arterial-internal jugular vein differences for 6-OHB and glucose. In Table I (Table II) .
Mean A-V differences for glucose tended to decrease with progressive hypoglycemia reaching a low point at the 45 min interval. A representative sequence of changes for one subject is shown in Fig. 4 .
Catecholamine excretion.. The urinary catecholamines, measured in five subjects of the group, increased from a mean of 55±13 sgI24 hr on the day before, to 107±21 ttgI24 hr on the day of the insulin tolerance test. This increase was significant (P < 0.01) and is in accord with the responses reported in healthy normal subjects (8) . At the end of the fast period the urinary catecholamines on the day before the test measured 56±11 /ug/24 hr and 81±10 /g/'24 hr oIn the test day. This difference proved to be not significant (P > 0.1). Increments in catecholamline excretion were then correlated to various expressions of change in glucose concentrations. Before fasting, the zero order correlation coefficient for the absolute glucose nadir was 0.854 (r > 0.95), for per cent fall of glucose 0.742 and for k-values 0.544. In contrast, after fasting, the respective coefficients were 0.684, 0.707, and 0.135. suggesting a diminishing correlation. Because I of the small sample size this trend could not be proven to be signiificant, using the Z-statistic to test for a difference between correlation coefficients. DISCUSSION Under normal circumstanices the energy requirements of the brain are supplied almost exclusively by oxidation of glucose. In prolonged fasting, the brain adapts to the reduction in available glucose and to the abundance of ketones by an enhanced uptake of the latter. An arteriovenous 13-OHB difference across the brain of fasting humans of 0.34 mmoles suggested efficient extraction by intracranial tissues (1) . In the brain of fasting rats, increased activity of i-OHB dehydrogenase was demonstrated in one study (9) but not in another (10) . Brains of patients dying of ketoacidosis were found to have increased quantities of enzymes involved in the metabolism of ketones (11) . It had also been shown that ketoacids can replace glucose when tissue from ketotic rats is incubated with these substrates (12) (13) (14) . Although it had been demonstrated that fasted mice were more resistant to the convulsant effect of insulin (2) it was not known if the fasted human brain could tolerate an acute fall in glucose concentrations to very low levels without the development of hypoglycemic manifestations.
Satisfactory evidence for such an adaptation had to be sought in subjects who had actually experienced symptomatic hypoglycemic reactions before fasting but proved insensitive to the stress of equally severe hypoglycemic episodes after fasting. Davidson and Albrink (15) had noted that the blood sugar-lowering effect of insulin in overweight subjects was inversely proportional to the degree of obesity. In accord with these observations, overt insulin reactions occurred in only 12 of 51 massively obese subjects even through insulin doses of up to 0.2 U/kg of body weight were used.
The experimental conditions during the prefast and postfast tests were equivalent with regard to maximum insulin concentrations and disappearance rates. An unaltered lipolytic effect of the injected insulin was demonstrated by equivalent percentage falls in serum FFA before and after the fast. The per cent fall in blood sugar levels up to 30 min after insulin was slightly less after fasting but it was not significantly different from prefast tests. These results are in agreement with the observations of others who performed insulin tolerance tests in obese subjects after 14-day fasts (16) . The hypoglycemic effect of insulin after the fast was more prolonged producing a nadir at the 60 min interval. It appears unlikely therefore, that the slightly more sluggish decline of glucose after fasting could have been responsible for the observed reduction in adrenergic responses. One subject, not included in this group, was inadvertently given the same dose of insulin prefast and postfast. The amount of insulin/kg and the extent and rate of glucose fall were considerably greater than prefast. Nonetheless, no insulin reaction occurred although this subject had had a violent reaction prefast.
It could be argued that fasting may have induced a degree of resistance to adrenergic stimuli in the receptor tissues but this possibility appears to be less likely in view of the fact that manifestations of a primary disturbance of cerebral function, such as confusion, were abolished as well. These latter manifestations are presumed to result from direct interference with brain cell metabolism rather than from epinephrine release.
To make a plausible argument for the substitution of ketones as a central nervous system fuel in place of glucose a net decrease in plasma ketone levels as well as an enhanced extraction of ketones from blood passing through the brain should be demonstrable. The observed initial fall in serum 3-OHB levels after insulin injection could be explained in several ways. First, inhibition of lipolysis may result in a relative lack of substrate for hepatic ketogenesis. Secondly, as shown by Foster, insulin may inhibit ketogenesis by a direct effect upon the liver (17) .
Third, fuel-starved tissues, peripheral as well as brain, may utilize more 8-OHB (18) . Finally, a combination of any of the three factors may be operative.
During the initial phase, that is up to the 30-min interval, the reduction in FFA levels may have contributed to the lowering in plasma 8-OHB although observations by Bieberdorf, Chernick, and Scow indicated that insulin suppressed ketogenesis independent of plasma FFA levels (19) . However at the 2 hr interval, #-OHB levels remained depressed in several subjects while at the same time serum FFA levels had returned to the original elevated fasting levels. This dissociation suggests that a lack of precursor substrate for ketogenesis was not in- (11), and Gottstein et al. (20) that cerebral uptake of #-OHB is proportional to the concentration in the circulating blood. During steady-state conditions for glucose and f-OHB concentrations this relationship appears to be confirmed. However, in this study, the increasing A-V differences in the early postinsulin phase-whereas plasma glucose and 8-OHB levels fall-suggest that under these circumstances uptake is not exclusively a function of plasma substrate concentration. The threefold increases in A-V differences across the brain with progressive hypoglycemia contrast with a simultaneous threefold diminution in A-V differences of blood glucose. The increase in cerebral #-OHB extraction appeared inordinately high when one attempts to relate it to reported rates of 02 uptake. A satisfactory explanation for this phenomenon is not at hand. The possibility should be considered that not all of the p-OHB A-V difference reflects terminal oxidation. Alternate pathways with conversion to amino acids or glucogenic intermediates or removal into cerebrospinal fluid (21) could contribute to the A-V difference. However, an enhanced cerebral consumption of substrates other than glucose would seem to be likely in glucopenia. It had been shown by Eisenberg and Seltzer (22) that cerebral glucose utilization decreased during insulin hypoglycemia while 02 consumption rose significantly. They also demonstrated that the rate of blood flow did not change during the hypoglycemic phase so that the increasing A-V difference of 6-OHB in this study is likely to reflect increased cerebral uptake. While Balasse and Havel (18) postulated that insulin enhances P-OHB utilization by peripheral tissues this could not be demonstrated on the basis of A-V differences across the forearm of the subjects in this group. In fact, some of the venous 8-OHB levels were slightly higher than the arterial concentration indicating, perhaps, conversion of acetoacetate to 8-OHB in peripheral tissue. Similar findings had been reported by Owen and Reichard (23) . The lack of uptake of 13-OHB by forearm tissue vs. enhanced uptake by cerebral tissue constitutes a further argument in favor of the hypothesis that in fasting and particularly during acute glucopenia glucose is replaced by ketones as a fuel for the central nervous systemi.
The data in this study do not permit a definite explanation for the lagging return to normal of lowered glucose levels. One might speculate that in the absence of a significant catecholarmine response in the adapted subject, hepatic glycogenolysis is depressed. In addition, it is conceivable that restoration of normal glucose levels was delayed because hepatic glycogen stores, after prolonged fasting, may be reduced to some degree. Finally, it may be possible that in the presence of ample ketones the stimulus for gluconeogenesis is diminished.
Of interest is the observation that the effect of large doses of exogenous insulin upon glucose disposal and lipolysis was virtually unaltered after fasting. This is surprising in view of the commonly reported "starvation diabetes," which, in the opinion of some, is caused by an increased resistance to the effect of insulin (24) .
The findings of this study suggest a possible clinical application. Brittle diabetics, subject to recurrent symnptomatic insulin reactions, may possibly benefit from eating ketogenic diets. Another intriguing speculation concerns the amelioration of epilepsy in children treated with ketogenic diets. No satisfactory explanation for the beneficial effect had been offered in the past. Possibly, cerebral adaptation to the utilization of ketones renders the epilepsy-prone child less vulnerable to the potentially irritant sequels of a fall in glucose concentratioin.
